ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 26 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,320 | -5.4% | 6,000 | 0.0% | 0.07% | -1.3% |
| Q2 2023 | $429,420 | +3.1% | 6,000 | 0.0% | 0.08% | -2.6% |
| Q1 2023 | $416,460 | +2.4% | 6,000 | 0.0% | 0.08% | -3.8% |
| Q4 2022 | $406,800 | +23.6% | 6,000 | 0.0% | 0.08% | +15.9% |
| Q3 2022 | $329,000 | -16.9% | 6,000 | 0.0% | 0.07% | -10.4% |
| Q2 2022 | $396,000 | -0.5% | 6,000 | 0.0% | 0.08% | +14.9% |
| Q1 2022 | $398,000 | +13.7% | 6,000 | 0.0% | 0.07% | +15.5% |
| Q4 2021 | $350,000 | -2.8% | 6,000 | 0.0% | 0.06% | -7.9% |
| Q3 2021 | $360,000 | +0.3% | 6,000 | 0.0% | 0.06% | 0.0% |
| Q2 2021 | $359,000 | +20.5% | 6,000 | 0.0% | 0.06% | +14.5% |
| Q1 2021 | $298,000 | -0.7% | 6,000 | 0.0% | 0.06% | -8.3% |
| Q4 2020 | $300,000 | -8.8% | 6,000 | 0.0% | 0.06% | -23.1% |
| Q3 2020 | $329,000 | +3.8% | 6,000 | 0.0% | 0.08% | -4.9% |
| Q2 2020 | $317,000 | +18.3% | 6,000 | 0.0% | 0.08% | -6.8% |
| Q1 2020 | $268,000 | -10.4% | 6,000 | 0.0% | 0.09% | +15.8% |
| Q4 2019 | $299,000 | -4.2% | 6,000 | -14.3% | 0.08% | -14.6% |
| Q3 2019 | $312,000 | +8.0% | 7,000 | 0.0% | 0.09% | +7.2% |
| Q2 2019 | $289,000 | +2.1% | 7,000 | 0.0% | 0.08% | +2.5% |
| Q1 2019 | $283,000 | -0.7% | 7,000 | -6.7% | 0.08% | -12.0% |
| Q4 2018 | $285,000 | -4.0% | 7,500 | 0.0% | 0.09% | +15.0% |
| Q3 2018 | $297,000 | +12.9% | 7,500 | 0.0% | 0.08% | +8.1% |
| Q2 2018 | $263,000 | +0.4% | 7,500 | 0.0% | 0.07% | 0.0% |
| Q1 2018 | $262,000 | -5.8% | 7,500 | -6.2% | 0.07% | -3.9% |
| Q4 2017 | $278,000 | -8.9% | 8,000 | -11.1% | 0.08% | -12.5% |
| Q3 2017 | $305,000 | +12.1% | 9,000 | +12.5% | 0.09% | +6.0% |
| Q2 2017 | $272,000 | +9.2% | 8,000 | 0.0% | 0.08% | +5.1% |
| Q1 2017 | $249,000 | +14.2% | 8,000 | 0.0% | 0.08% | +5.3% |
| Q4 2016 | $218,000 | -21.9% | 8,000 | -5.9% | 0.08% | -25.7% |
| Q3 2016 | $279,000 | – | 8,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |